CAS 1057-07-4

Dihydrotestosterone benzoate

Description:

Dihydrotestosterone benzoate (DHT benzoate) is a synthetic derivative of dihydrotestosterone (DHT), a potent androgen hormone. It is characterized by its benzoate ester, which enhances its lipophilicity and alters its pharmacokinetic properties. DHT itself is a metabolite of testosterone and plays a crucial role in the development of male characteristics and reproductive functions. The benzoate form is often utilized in research and therapeutic applications, particularly in hormone replacement therapies and studies related to androgenic effects. DHT benzoate is typically administered via intramuscular injection, allowing for sustained release and prolonged action in the body. Its chemical structure includes a steroid backbone with a benzoate group, contributing to its stability and solubility in organic solvents. As with other androgens, it can influence various physiological processes, including muscle growth, hair loss, and libido. However, its use must be carefully monitored due to potential side effects associated with androgenic activity, such as acne, hair loss, and changes in mood.

Formula: C₂₆H₃₄O₃

InChI: InChI=1/C26H34O3/c1-25-14-12-19(27)16-18(25)8-9-20-21-10-11-23(26(21,2)15-13-22(20)25)29-24(28)17-6-4-3-5-7-17/h3-7,18,20-23H,8-16H2,1-2H3/t18-,20-,21-,22-,23-,25-,26-/m0/s1

InChI key: InChIKey=ZGDZDAPCWHIIKB-LVYWIKMTSA-N

SMILES: C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)[C@@H](OC(=O)C5=CC=CC=C5)CC4)[H])(CC[C@]1(CC(=O)CC2)[H])[H])[H]

Synonyms:

• (5Alpha,17Beta)-3-Oxoandrostan-17-Yl Benzoate
• (5α,17β)-17-(Benzoyloxy)androstan-3-one
• 5-Alpha-17-Beta-Hydroxyandrostan-3-One Benzoate
• 5α-Androstan-3-one, 17β-hydroxy-, benzoate
• 5α-Dihydrotestosterone benzoate
• Androstan-3-one, 17-(benzoyloxy)-, (5α,17β)-
• Androstanolone benzoate
• Dihydrotestosterone benzoate
• Ermalone
• Hermalone
• NSC 69549
• Sarcosan
• 5ALPHA-ANDROSTAN-17BETA-OL-3-ONE 17-BENZOATE
• DIHYDROTESTOSTERONE HEXAHYDROBENZOATE
• benzoic acid [(5S,8R,9S,10S,13S,14S,17S)-3-keto-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] ester
• 5A-androstan-17B-ol-3-one benzoate--*dea schedule
• 17BETA-HYDROXY-5ALPHA-ANDROSTAN-3-ONE 17-BENZOATE
• 17-(benzoyloxy)-,(5-alpha,17-beta)-androstan-3-on
• [(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] benzoate
• androstanolonebenzoate
• 5a-Androstan-17b-ol-3-one benzoate
• STANOLONE BENZOATE
• 5ALPHA-ANDROSTAN-17BETA-OL-3-ONE BENZOATE
• 17β-hydroxy-5α-androstan-3-one 17-benzoate
• analyticalstandard
• DHTB
• 5A-ANDROSTAN-17B-OL-3-ONE BENZOATE--DEA SCHEDULE I
• 5ALPHA-DIHYDROTESTOSTERONE BENZOATE
• 5-ALPHA-ANDROSTAN-17-BETA-OL-3-ONE HEXAHYDROBENZOATE
• 17-beta-hydroxy-5-alpha-androstan-3-onbenzoate
• 5α-Androstan-17β-ol-3-one benzoate
• ANDROSTANOLONE 17-BENZOATE
• 3-OXO-5A-ANDROSTAN-17B-YL BENZOATE
• (5-alpha,17-beta)-17-(benzoyloxy)androstan-3-one

Stanolone benzoate

Controlled Product

CAS: 1057-07-4

Stanolone benzoate is a synthetic hormone that has been used as an oral contraceptive. It binds to the estrogen receptor and inhibits the production of estradiol, which is a natural hormone in women. This drug also has anti-inflammatory properties, which may be due to its ability to inhibit fatty acid synthesis or prostaglandin synthesis. Stanolone benzoate may cause side effects such as nausea, headache, dizziness, and breast tenderness.

Formula: C₂₆H₃₄O₃

Purity: Min. 95%

Molecular weight: 394.5 g/mol

Ref: 3D-BAA05707